New Partnership Aims to Reduce Diabetic Foot Amputations with Innovative Technology

A groundbreaking partnership between AlexiGen, Sensoria Health, Defender, and Anderson Medical Supplies has been announced, aiming to revolutionize the management of diabetic foot ulcers (DFUs) and reduce the risk of amputations. The collaboration, unveiled at the DFCon Conference Symposium in Los Angeles, introduces the 'Alternative to Amputation: Footwear as a Service (FAAS)' - a remote patient monitoring artificial intelligence platform.

This innovative approach combines advanced biologics, remote monitoring technology, wound care solutions, and specialized footwear to provide a more effective strategy for DFU management. The partnership addresses a critical health issue, as approximately 15% of people with diabetes develop foot ulcers, with 6% requiring hospitalization due to complications. More alarmingly, between 14% and 24% of individuals with diabetic foot ulcers ultimately face amputation.

The FAAS platform integrates several key components: Anderson Medical Supplies will offer dedicated patient monitoring clinical services, AlexiGen will provide skin graft products, while Defender and Sensoria will contribute their Smart Boot and remote patient monitoring services. The Defender smart boot, equipped with Sensoria Health's sensor and software technology, is currently undergoing validation in an NIH-funded clinical study conducted by the University of Southern California and Baylor College of Medicine.

This collaborative effort represents a significant step forward in diabetic foot care. By combining real-time patient monitoring, advanced biologics, and specialized clinical services, the platform has the potential to dramatically improve outcomes for DFU patients. The remote monitoring capabilities allow healthcare providers to track patient adherence to treatment plans, ensuring optimal use of therapies and potentially reducing the need for hospitalizations and amputations.

The implications of this partnership extend beyond individual patient care. If successful, this approach could lead to substantial cost savings in healthcare systems worldwide by reducing the need for expensive interventions and long-term care associated with amputations. Moreover, it could significantly improve the quality of life for millions of diabetic patients at risk of foot complications.

As the platform becomes available, the partnership is seeking early adopters among clinicians, podiatry and wound care clinics to further validate and refine this holistic approach to treating diabetic foot ulcers. The success of this initiative could mark a paradigm shift in the management of chronic wounds and serve as a model for addressing other complex, long-term health conditions through integrated, technology-driven care solutions.